Ultimately, SYNTHIA hopes to build trust regarding the usefulness of synthetic data and facilitate its responsible use by researchers.
Ultimately, SYNTHIA hopes to build trust regarding the usefulness of synthetic data and facilitate its responsible use by researchers.
Find out about the scope of IHI call 9 and learn how to get the most out of our brokerage platform and event.
VAC2VAC provided vital evidence to demonstrate that non-animal alternatives can reliably detect certain contaminants in medicines administered by injection.
Hitting the 200 project milestone shows the strength of the public-private partnership approach pioneered by the Innovative Medicines Initiative and built on by IHI.
How a patient-centric approach, data solutions and digital innovations are making a difference
Drugs for IBD work in some patients, but not others. The Immune-Image project used imaging techniques to illuminate how the vedolizumab drug works in IBD patients, which could shed...
Health research collaborations mean sharing data – we can deliver faster if we identify and remove obstacles early, write IHI's Niklas Blomberg and EFPIA's Magda Chlebus.
The NECESSITY project carried out a study that showed that Sjögren’s patients can be categorised into three different subgroups, meaning that more personalised and better...